GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alcon Inc (NYSE:ALC) » Definitions » Stock Based Compensation

Alcon (ALC) Stock Based Compensation : $37 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Alcon Stock Based Compensation?

Alcon's Stock Based Compensation for the three months ended in Dec. 2023 was $0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was $37 Mil.


Alcon Stock Based Compensation Historical Data

The historical data trend for Alcon's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon Stock Based Compensation Chart

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial 83.00 105.00 138.00 140.00 144.00

Alcon Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.00 - - - -

Alcon Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $37 Mil.


Alcon Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Alcon's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Alcon (ALC) Business Description

Traded in Other Exchanges
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Alcon (ALC) Headlines

From GuruFocus

Top 5 2nd Quarter Trades of Performa Ltd (US), LLC

By GuruFocus Research GuruFocus Editor 08-03-2022

Alcon Announces Results of 2023 Annual General Meeting

By Business Wire Business Wire 05-05-2023

Alcon to Host 2023 Capital Markets Day

By Business Wire Business Wire 03-20-2023

Alcon Canada launches new TOTAL toric lenses for astigmatic patients

By Business Wire Business Wire 02-02-2023

Alcon Publishes Agenda for 2023 Annual General Meeting

By Business Wire Business Wire 03-29-2023